$0.650
-0.040 (-6.15%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
HUMA 相似图表分析预测
Alphio's HUMA stock price prediction model matches the current Humacyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.65 (+0.61%). The 1-week path is $0.66 (+0.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Humacyte Inc 股票吗？
Humacyte Inc is currently priced at $0.6501, which is significantly below the analyst price targets of $1 to $4, indicating potential upside. However, the company has a high forward P/E of 35.84, suggesting that it may be overvalued relative to its earnings potential. Additionally, the recent RSI of 45.646 indicates that the stock is neither overbought nor oversold, suggesting caution. The main risk is the company's significant net income loss of -36802000 in Q2 2026, which raises concerns about its financial health.
HUMA 股价于 Friday 收于 $0.65，此前下跌 -6.15%
Humacyte Inc (HUMA) last closed at $0.6501, losing -6.15%. These facts feed the 1-day and 1-week HUMA price prediction above.
预测驱动因素
Humacyte Inc（HUMA）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 HUMA 最接近的股票，按相似度排序。
HUMA 季节性分析
Historically the probability of a positive August return for HUMA is 34.92%. February offers the highest probability of a positive month at 62.07%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。